NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
25.76
+0.76 (3.04%)
At close: Aug 13, 2025, 4:00 PM
26.28
+0.52 (2.02%)
Pre-market: Aug 14, 2025, 7:17 AM EDT
NAMS Market Cap
NAMS has a market cap or net worth of $2.90 billion as of August 14, 2025. Its market cap has increased by 70.95% in one year.
Market Cap
2.90B
Enterprise Value
2.12B
1-Year Change
70.95%
Ranking
Category
Stock Price
$25.76
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $2.90B, an increase of 1,778.49%. That is a compound annual growth rate of 91.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.82B | 2.34% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 588.47B |
| Johnson & Johnson | 419.32B |
| AbbVie | 355.22B |
| UnitedHealth Group | 244.66B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.39B |
| Novo Nordisk | 223.00B |